Pathogenesis and Clinical Features of Spontaneous Bacterial Peritonitis

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment: Second Edition

Volumn , Issue , 2007, Pages 422-433

  Such, José ^a   Guarner, Carlos ^a,b   Runyon, Bruce A ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Liver transplantation; Pathogenesis; Prophylaxis; Spontaneous bacterial peritonitis (SBP)

Indexed keywords

EID: 84889271075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987476.ch34     Document Type: Chapter

References (144)

1. Conn HO, Fessell J.M. Spontaneous bacterial peritonitis and bacteremia in cirrhotic patients caused by enteric bacteria. Ann Intern Med 1964; 60: 568-80.
2. Runyon B.A. Spontaneous bacterial peritonitis: an explosion of information. Hepatology 1988; 8: 171-5.
3. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-8.
4. McHutchinson JG, Runyon B.A. Spontaneous bacterial peritonitis. In: Surawicz CM, Owen RL, eds. Gastrointestinal and Hepatic Infections. Philadelphia: W.B. Saunders, 1994; 455-75.
5. Runyon BA, Hoefs J.C. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984; 4: 1209-11.
6. Terg R, Levi D, Lopez P et al. Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci 1992; 37: 1499-504.
7. Runyon B.A. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 1990; 12: 710-15.
8. Chu CM, Chang KY, Liaw Y.F. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci 1995; 40: 561-5.
9. Guarner C, Runyon B.A. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management. Gastroenterologist 1995; 3: 311-28.
10. Wu SS, Lin OS, Chen YY et al. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol 2001; 34: 215-21.
11. Runyon BA, Hoefs J.C. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 1984; 4: 447-50.
12. Runyon BA, Hoefs JC, Canawati H.N. Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid. Arch Intern Med 1986; 146: 2173-5.
13. Xiol X, Castellvi JM, Guardiola J et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23: 719-23.
14. Planas R, Arroyo V. Spontaneous bacterial peritonitis. Acta Gastroenterol Belg 1995; 58: 297-310.
15. Llovet JM, Rodriguez Iglesias P, Moitinho E et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol 1997; 26: 88-95.
16. Such J, Guarner C, Enriquez J et al. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1988; 6: 80-4.
17. Simon GL, Gorbach S.L. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-93.
18. Scheckman P, Onderdonk AB, Bartlett J.C. Anaerobes in spontaneous peritonitis. Lancet 1977; 2:1233.
19. Ginès P, Rimola A, Planas R et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12: 716-24.
20. Soriano G, Guarner C, Teixidó M et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991; 100: 477-81.
21. Soriano G, Guarner C, Tomas A et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-72.
22. Novella M, Sola R, Soriano G et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997; 25: 532-6.
23. Aparicio JR, Such J, Pascual S et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999; 31: 277-83.
24. Cereto F, Molina I, González A et al. Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2003; 17: 695-701.
25. Fernandez J, Navasa M, Gómez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
26. Campillo B, Richardet JP, Kheo T et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002; 35: 1-10.
27. Rimola A, Bory F, Terés J et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5: 463-7.
28. Such J, Guarner C, Soriano G et al. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 1990; 12: 1175-8.
29. Bauer TM, Schwacha H, Steinbruckner B et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000; 33: 382-6.
30. Casafont Morencos F, De Las Heras Castano G, Martin Ramos L et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996; 41: 552-6.
31. Yang CY, Chang CS, Chen G.H. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 1998; 33: 867-71.
32. Chang CS, Yang SS, Kao CH et al. Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol 2001; 36: 92-6.
33. Guarner C, Runyon BA, Young S et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372-8.
34. Hauge T, Persson J, Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion 1997; 58: 591-5.
35. Fried M, Siegrist H, Frei R et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35: 23-6.
36. Raedsch R, Stiehl A, Gundert-Remy U et al. Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver. Digestion 1983; 26: 80-8.
37. Chesta J, Defilippi C, Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 1993; 17: 828-32.
38. Lorenzo-Zuniga V, Bartoli R, Planas R et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 2003; 37: 551-7.
39. Pardo A, Bartoli R, Lorenzo-Zuniga V et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-63.
40. Such J, Guardiola JV, de Juan J et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 2002; 14: 371-6.
41. Nagral AS, Joshi AS, Bhatia SJ et al. Congestive jejunopathy in portal hypertension. Gut 1993; 34: 694-7.
42. Pascual S, Such J, Esteban A et al. Intestinal permeability is increased in patients with advanced cirrhosis and associated clinical complications. Hepatogastroenterology 2003; 50: 1482-6.
43. Deitch EA, Specian RD, Berg R.D. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991; 19: 785-91.
44. Deitch EA, Xu DZ, Qi L et al. Bacterial translocation from the gut impairs systemic immunity. Surgery 1991; 109: 269-76.
45. Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139-43.
46. Berg RD, Garlington A.W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
47. Llovet JM, Bartoli R, March F et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998; 28: 307-13.
48. Cirera I, Bauer TM, Navasa M et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34: 32-7.
49. Such J, Frances R, Munoz C et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002; 36: 135-41.
50. Connell H, Hedlund M, Agace W et al. Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Adv Dent Res 1997; 11: 50-8.
51. Siitonen A. Escherichia coli in fecal flora of healthy adults: serotypes, P and type 1C fimbriae, non-P mannoseresistant adhesins, and hemolytic activity. J Infect Dis 1992; 166: 1058-65.
52. Soriano G, Coll P, Guarner C et al. Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis. Hepatology 1995; 21: 668-73.
53. Williams RC, Gibbons R.J. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 1972; 177: 697-9.
54. Pelletier G, Briantais MJ, Buffet C et al. Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut 1982; 23: 475-80.
55. Albillos A, De La Hera A. Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants. J Hepatol 2002; 37:523.
56. Chiva M, Soriano G, Rochat I et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002; 37:456.
57. Garcia-sao G, Lee FY, Barden GE et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1835-41.
58. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21: 792-6.
59. Runyon BA, Borzio M, Young S et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995; 21: 1719-24.
60. Llovet JM, Bartoli R, Planas R et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996; 23: 781-7.
61. Bauer TM, Fernandez J, Navasa M et al. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 2002; 36: 501-6.
62. Wells CL, Maddaus MA, Simmons R.L. Role of the macrophage in the translocation of intestinal bacteria. Arch Surg 1987; 122: 48-53.
63. Ding JW, Andersson R, Soltesz VL et al. Inhibition of bacterial translocation in obstructive jaundice by muramyl tripeptide phosphatidylethanolamine in the rat. J Hepatol 1994; 20: 720-8.
64. Genesca J, Marti R, Rojo F et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003; 52: 1054-9.
65. Wells CL, Maddaus MA, Jechorek RP et al. Ability of intestinal Escherichia coli to survive within mesenteric lymph nodes. Infect Immun 1987; 55: 2834-7.
66. Palazon JM, Requena J, Plazas J et al. Anticuerpos contra enterobacterias y peritonitis bacteriana espontánea en la cirrosis hepática. Gastroenterol Hepatol 1994; 17: 460-5.
67. Young LS, Martin WJ, Meyer RD et al. Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med 1977; 86: 456-71.
68. Feliu E, Gougerot MA, Hakim J et al. Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis. Eur J Clin Invest 1977; 7: 571-7.
69. Rajkovic IA, Williams R. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci 1985; 68: 247-53.
70. Lebrun L, Pelletier G, Briantais MJ et al. Impaired functions of normal peripheral polymorphonuclear leukocytes in cirrhotic ascitic fluid. J Hepatol 1992; 16: 98-101.
71. Garcia Gonzalez M, Boixeda D, Herrero D et al. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 1993; 105: 527-31.
72. LaffiG, Carloni V, Baldi E et al. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterology 1993; 105: 170-7.
73. Cornacoff JB, Hebert LA, Smead WL et al. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 1983; 71: 236-47.
74. Gomez F, Ruiz P, Schreiber A.D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331: 1122-8.
75. Hassner A, Kletter Y, Shlag D et al. Impaired monocyte function in liver cirrhosis. Br Med J (Clin Res Ed) 1981; 282: 1262-3.
76. Rimola A, Soto R, Bory F et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.
77. Yousif Kadaru AG, Rajkovic IA, Wyke RJ et al. Defects in serum attractant activity in different types of chronic liver disease. Gut 1984; 25: 79-84.
78. Naveau S, Poynard T, Abella A et al. Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients. Hepatology 1985; 5: 819-23.
79. Runyon B.A. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91: 1343-6.
80. Runyon BA, Morrissey RL, Hoefs JC et al. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 1985; 5: 634-7.
81. Homann C, Varming K, Hogasen K et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997; 40: 544-9.
82. Llach J, Rimola A, Navasa M et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16: 724-7.
83. Fromkes JJ, Thomas FB, Kraut E.H. Activation of the alternative complement pathway in ascitic fluid during spontaneous bacterial peritonitis. J Clin Gastroenterol 1982; 4: 347-50.
84. Runyon BA, Van Epps D.E. Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis. Hepatology 1986; 6: 396-9.
85. Runyon BA, Antillon MR, McHutchison J.G. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. J Hepatol 1992; 14: 249-52.
86. Runyon BA, Antillon MR, Montano A.A. Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement. Gastroenterology 1989; 97: 158-62.
87. Sola R, Andreu M, Coll S et al. Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study. Hepatology 1995; 21: 340-4.
88. Rosa H, Silverio AO, Perini RF et al. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 2000; 95: 1290-3.
89. Bleichner G, Boulanger R, Squara P et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986; 73: 724-6.
90. Carr FK, Loegering D.J. Reticuloendothelial system function and humoral factor deficiency following acute hemorrhage. Can J Physiol Pharmacol 1978; 56: 299-303.
91. Deitch EA, Morrison J, Berg R et al. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibioticdecontaminated rats. Crit Care Med 1990; 18: 529-36.
92. Andreu M, Sola R, Sitges Serra A et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104: 1133-8.
93. Akriviadis EA, Runyon B.A. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98: 127-33.
94. Ljubicic N, Bilic A, Kopjar B. Diuretics vs. paracentesis followed by diuretics in cirrhosis: effect on ascites opsonic activity and immunoglobulin and complement concentrations. Hepatology 1994; 19: 346-53.
95. Yoshida H, Hamada T, Inuzuka S et al. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993; 88: 2067-71.
96. Guarner C, Sola R, Soriano G et al. Risk of a first communityacquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999; 117: 414-19.
97. Ho H, Zuckerman MJ, Ho TK et al. Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis. Am J Gastroenterol 1996; 91: 735-42.
98. Graudal N, Milman N, Kirkegaard E et al. Bacteremia in cirrhosis of the liver. Liver 1986; 6: 297-301.
99. Barnes PF, Arevalo C, Chan LS et al. A prospective evaluation of bacteremic patients with chronic liver disease. Hepatology 1988; 8: 1099-103.
100. Hoefs JC, Runyon B.A. Spontaneous bacterial peritonitis. Dis Mon 1985; 31: 1-48.
101. Tam F, Chow H, Prindiville T et al. Bacterial peritonitis following esophageal injection sclerotherapy for variceal hemorrhage. Gastrointest Endosc 1990; 36: 131-3.
102. Schembre D, Bjorkman D.J. Post-sclerotherapy bacterial peritonitis. Am J Gastroenterol 1991; 86: 481-6.
103. Rolando N, Gimson A, Philpott-Howard J et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 1993; 18: 290-4.
104. Bac DJ, de Marie S, Siersema PD et al. Post-sclerotherapy bacterial peritonitis: a complication of sclerotherapy or of variceal bleeding? Am J Gastroenterol 1994; 89:859-62.
105. Blaise M, Pateron D, Trinchet JC et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20: 34-8.
106. Titó L, Rimola A, Ginès P et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27-31.
107. Bar Meir S, Lerner E, Conn H.O. Analysis of ascitic fluid in cirrhosis. Dig Dis Sci 1979; 24: 136-44.
108. Conn HO, Fessel J.M. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine Baltimore 1971; 50: 161-97.
109. Weinstein MP, Iannini PB, Stratton CW et al. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64: 592-8.
110. Rimola A, Garcia-TSAO G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142-53.
111. Rimola A. Infecciones bacterianas en la cirrosis hepática. MTA-Medicina Interna 1987; 5: 161-224.
112. Gimson A.E. Hepatic dysfunction during bacterial sepsis. Intensive Care Med 1987; 13: 162-6.
113. Pinzello G, Simonetti RG, Craxi A et al. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983; 3: 545-9.
114. Llovet JM, Planas R, Morillas R et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993; 88: 388-92.
115. Hoefs J.C. Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology 1981; 1: 249-54.
116. Castellote J, Lopez C, Gornals J et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips. Hepatology 2003; 37: 893-6.
117. Runyon B.A. Strips and tubes: improving the diagnosis of spontaneous bacterial peritonitis. Hepatology 2003; 37: 745-7.
118. Runyon BA, Canawati HN, Akriviadis E.A. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95: 1351-5.
119. Runyon BA, Hoefs J.C. Spontaneous vs secondary bacterial peritonitis. Differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy. Arch Intern Med 1986; 146: 1563-5.
120. Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis. Arch Intern Med 1987; 147: 73-5.
121. Sainz S, Soriano G, Guarner C et al. More on ascitic fluid culture technique [letter]. Hepatology 1989; 9: 662-3.
122. Castellote J, Xiol X, Verdaguer R et al. Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Am J Gastroenterol 1990; 85: 1605-8.
123. Runyon BA, Antillon MR, Akriviadis EA et al. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990; 28: 2811-12.
124. Ortiz J, Soriano G, Coll P et al. Early microbiologic diagnosis of spontaneous bacterial peritonitis with BacT/ALERT. J Hepatol 1997; 26: 839-44.
125. Evans LT, Kim WR, Poterucha JJ et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37: 897-901.
126. Cappell MS, Shetty V. A multicenter, case-controlled study of the clinical presentation and etiology of ascites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients. Am J Gastroenterol 1994; 89: 2172-7.
127. Such J, Hillebrand DJ, Guarner C et al. Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2004; 16: 571-7.
128. Navasa M, Follo A, Filella X et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27: 1227-32.
129. Such J, Hillebrand DJ, Guarner C et al. Tumor necrosis factor alpha, interleukin-6 and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001; 46: 2360-6.
130. Dwivedi M, Misra SP, Misra V et al. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites. Am J Gastroenterol 1990; 85: 1123-5.
131. Martinez-Vazquez JM, Ocana I, Ribera E et al. Adenosine deaminase activity in the diagnosis of tuberculous peritonitis. Gut 1986; 27: 1049-53.
132. Hillebrand DJ, Runyon BA, Yasmineh WG et al. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology 1996; 24: 1408-12.
133. Curry N, McCallum RW, Guth P.H. Spontaneous bacterial peritonitis in cirrhotic ascites. A decade of experience. Am J Dig Dis 1974; 19: 685-92.
134. Toledo C, Salmeron JM, Rimola A et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17: 251-7.
135. Albillos A, Cuervas Mons V, Millan I et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990; 98: 134-40.
136. Runyon BA, Antillon M.R. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection. Hepatology 1991; 13: 929-35.
137. Hoefs J.C. Spontaneous bacterial peritonitis: prevention and therapy. Hepatology 1990; 12: 776-81.
138. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 2001; 96: 1232-6.
139. Felisart J, Rimola A, Arroyo V et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985; 5: 457-62.
140. Follo A, Llovet JM, Navasa M et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20: 1495-501.
141. Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.
142. Silvain C, Besson I, Ingrand P et al. Prognosis and longterm recurrence of spontaneous bacterial peritonitis in cirrhosis. J Hepatol 1993; 19: 188-9.
143. Altman C, Grange JD, Amiot X et al. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. J Gastroenterol Hepatol 1995; 10: 47-50.
144. Bac D.J. Spontaneous bacterial peritonitis: an indication for liver transplantation? Scand J Gastroenterol Suppl 1996; 218:38-42.